CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma

Cancer Research

Volumn 68, Issue 3, 2008, Pages 715-723

  Vallacchi, Viviana ^a   Daniotti, Maria ^a   Ratti, Francesca ^a   Di Stasi, Delia ^a   Deho, Paola ^a   De Filippo, Annamaria ^a   Tragni, Gabrina ^a   Balsari, Andrea ^a   Carbone, Antonino ^a   Rivoltini, Licia ^a   Parmiani, Giorgio ^a   Lazar, Noureddine ^b   Perbal, Bernard ^b   Rodolfo, Monica ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA7 INTEGRIN; ALPHA7BETA1 INTEGRIN; ALPHAVBETA5 INTEGRIN; CCN3 PROTEIN; INTEGRIN; INTEGRIN RECEPTOR; LAMININ; MATRIX PROTEIN; MESSENGER RNA; PROTEIN; SCLEROPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VITRONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISSEMINATED CANCER; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; LYMPH NODE METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; VISCERAL METASTASIS; XENOTRANSPLANTATION;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTEGRINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA; MICE; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSFECTION;

EID: 38849132123     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2103     Document Type: Article

References (41)

1. Johnson JP. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 1999;18:345-57.
2. Haass NK, Herlyn M. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 2005;10:153-63.
3. van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res 2001;305:285-98.
4. Kuphal S, Bauer R, Bosserhoff AK. Integrin signaling in malignant melanoma. Cancer Metastasis Rev 2005;24:195-222.
5. Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci 2006;119:3901-3.
6. Ginsberg MH, Partridge A, Shattil SJ. Integrin regulation. Curr Opin Cell Biol 2005;17:509-16.
7. Perbal B, Takigawa M. The CCN family of proteins: an overview. In: Perbal B, Takigawa M, editors. The CCN Proteins: A New Family of Cell Growth and Differentiation Regulators. London: Imperial College Press; 2005. p. 1-18.
8. Gupta R, Hong D, Iborra F, Sarno S, Enver T. NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells. Science 2007;316:590-3.
9. Perbal B. Related CCN proteins: multifunctional signalling regulators. Lancet 2004;363:62-4.
10. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 2001;54:57-79.
11. Chevalier G, Yeger H, Martinerie C, et al. novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol 1998;152:1563-75.
12. Lazar N, Panque N, Perbal B. New domain-specific CCN3 antibodies as unique tools for structural and functional studies. Cell Comm Signal. In press. 2008.
13. Perbal B. Nuclear localization of NOVH protein: a potential role for NOV in the regulation of gene expression. Mol Pathol 1999;52:84-91.
14. Perbal B. The CCN3 protein and cancer. Adv Exp Med Biol 2006;587:23-40.
15. Joliot V, Martinerie C, Dambrine G, et al. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 1992;12:10-21.
16. Planque N, Perbal B. A structural approach to the role of CCN (CYR61/CTGF-/NOV) proteins in tumourigenesis. Cancer Cell Int 2003;3:15.
17. Daniotti M, Oggionni M, Ranzani T, et al. BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 2004;23:5968-77.
18. Benini S, Perbal B, Zambelli D, et al. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 2005;24:4349-61.
19. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia. 2nd ed. Br J Cancer 1998;77:1-10.
20. Bleau AM, Planque N, Lazar N, et al. Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation. J Cell Biochem 2007;101:1475-91.
21. Ellis PD, Chen Q, Barker PJ, Metcalfe JC, Kemp PR. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol 2000;20:1912-9.
22. Lin CG, Leu SJ, Chen N, et al. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 2003;278:24200-8.
23. Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM, Lau LF. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J Biol Chem 2005;280:8229-37.
24. Lafont J, Thibout H, Dubois C, Laurent M, Martinerie C. NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival. Cell Commun Adhes 2005;12:41-57.
25. Fukunaga-Kalabis M, Martinez G, Liu ZJ, et al. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol 2006;175:563-9.
26. Lau LF, Lam SC. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999;248:44-57.
27. Kyurkchiev S, Yeger H, Bleau AM, Perbal B. Potential cellular conformations of the CCN3(NOV) protein. Cell Commun Signal 2004;2:9.
28. McCallum L, Price S, Planque N, et al. A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 2006;108:1716-23.
29. Planque N, Long Li C, Saule S, Bleau AM, Perbal B. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins. J Cell Biochem 2006;99:105-16.
30. Stark M, Hayward N. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 2007;67:2632-42.
31. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353:2135-47.
32. Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Science 2006;119:4803-10.
33. Lafont J, Laurent M, Thibout H, et al. The expression of novH in adrenocortical cells is down-regulated by TGF-β 1 through c-Jun in a Smad-independent manner. J Biol Chem 2002;277:41220-9.
34. Luo X, Ding L, Chegini N. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-β and regulation by TGF-β in leiomyoma and myometrial smooth muscle cells. Mol Hum Reprod 2006;12:245-56.
35. Hoek KS, Schlegel NC, Brafford P, et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 2006;19:290-302.
36. Rodolfo M, Daniotti M, Vallacchi V. Genetic progression of metastatic melanoma. Cancer Lett 2004;214:133-47.
37. Ellis PD, Metcalfe JC, Hyvonen M, Kemp PR. Adhesion of endothelial cells to NOV is mediated by the integrins αvβ3 and α5β1. J Vascular Res 2003;40:234-43.
38. Laurent M, Martinerie C, Thibout H, et al. NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-α-dependent mechanism. FASEB J 2003;17:1919-21.
39. Kramer RH, McDonald KA, Vu MP. Human melanoma cells express a novel integrin receptor for laminin. J Biol Chem 1989;264:15642-9.
40. Echtermeyer F, Schober S, Poschl E, von der Mark H, von der Mark K. Specific induction of cell motility on laminin by α7 integrin. J Biol Chem 1996;27:2071-5.
41. Kramer RH, Vu MP, Cheng YF, Ramos DM, Timpl R, Waleh N. Laminin-binding integrin α7β1: functional characterization and expression in normal and malignant melanocytes. Cell Regul 1991;2:805-17.